Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00067080
Status:
COMPLETED
Last Update Posted:
2017-08-22
First Post:
2003-08-11
Brief Title:
Safety of ICL670 vs Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis